CBIO · Crescent Biopharma, Inc. · Executive Compensation
$13.00
+0.09 (+0.70%)
At close · Nov 20
Return incl. dividend (before tax)
Market Cap
$505.64M
Shares
38.90M
Volume · Nov 20
422.38K
Avg daily vol (3M)
358.97K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Amy Reilly | chief communications officer | Appointed | 2025-07-31 |
| Rick Scalzo | chief financial officer | Appointed | 2025-07-31 |
| David Lubner | board of directors | Appointed | 2025-07-31 |
| Tanya Sengupta | executive vice president, chief of strategy and operations | Appointed | 2025-07-31 |
| Jan Pinkas | chief scientific officer | Appointed | 2025-07-31 |
| Joshua Brumm | member of the board of directors | Appointed | 2025-07-31 |
| Jonathan McNeill | president and chief operating officer | Appointed | 2025-07-31 |
| Ellie Im | chief medical officer | Appointed | 2025-07-31 |
| Joshua Brumm | chief executive officer | Appointed | 2025-07-31 |
| Jonathan Violin | director | Appointed | 2025-06-18 |
| Peter Harwin | Chair of the Board | Appointed | 2025-06-18 |
| Susan Moran | director | Appointed | 2025-06-18 |
| Joshua Brumm | director | Appointed | 2025-06-18 |
| David Lubner | director | Appointed | 2025-06-18 |
| Alexandra Balcom | director | Appointed | 2025-06-18 |
| Barbara Bispham | General Counsel and Corporate Secretary | Appointed | 2025-06-18 |
| Ryan Lynch | Treasurer, Senior Vice President of Finance and Chief Accounting Officer | Appointed | 2025-06-18 |
| Peter Harwin | director | Appointed | 2025-06-18 |
| Richard Scalzo | Chief Financial Officer | Appointed | 2025-06-18 |
| Christopher Doughty | Chief Business Officer | Appointed | 2025-06-18 |
| Ellie Im | Chief Medical Officer | Appointed | 2025-06-18 |
| Jonathan McNeill | Chief Operating Officer and President | Appointed | 2025-06-18 |
| Joshua Brumm | Chief Executive Officer | Appointed | 2025-06-18 |
| Brian Hahn | Principal Executive Officer and Principal Financial Officer | Resigned | 2025-06-18 |
|
Timothy Pearson
“On June 13, 2025, Patricia Andrews, Daniel Janius and Timothy Pearson resigned from the Company's board of directors and its committees on which they respectively served, which resignations were not the result of any disagreements with the Company relating to the Company's operations, policies or practices.”
|
director | Resigned | 2025-06-18 |
Leadership
- Harout Semerjian CEO, Board Member
- Joshua Brumm CEO, Board Member
- Peter Harwin Chairman, Board Member
- Richard Scalzo CFO
- Rick Scalzo CFO
- Jonathan McNeill COO
- Barbara Bispham General Counsel
- Barbara Bispham Hale General Counsel
- Ryan Lynch Chief Accounting Officer
- Alexandra Balcom Board Member
- David Lubner Board Member
- Jonathan Violin Board Member
- Scott Koenig Board Member
- Susan Moran Board Member
Key facts
CIK
1253689
CUSIP
G2545C104
13F (30d)
102 filings
99 filers
Visit website
Investor relations